Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Internal Medicine Neurology Oncology Pediatrics Respiratory Medicine Surgery
Congress Coverage
2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting

Keynote Webinar | Spotlight on Diet and Diabetes

Watch on-demand

An expert-led symposium exploring the prevention and management of type 2 diabetes through dietary interventions. 
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control

22-09-2023 | Colorectal Cancer | Original Paper

Prevalence and predictors of colorectal cancer screening in the United States: evidence from the HINTS database 2018 to 2020

Authors: Joseph Atarere, Christopher Haas, Ted Akhiwu, Thilini Delungahawatta, Ashik Pokharel, Comfort Adewunmi, Eugene Annor, Vwaire Orhurhu, Jasmine Barrow

Published in: Cancer Causes & Control

Login to get access

Abstract

Background

The incidence of colorectal cancer (CRC) and CRC-related mortality among young adults (< 50 years) has been on the rise. The American Cancer Society (ACS) reduced the CRC screening age to 45 in 2018. Few studies have examined the barriers to CRC screening among young adults.

Methods

Analyses were conducted using data from 7,505 adults aged 45–75 years who completed the 2018 to 2020 Health Information National Trends Survey. We examined the sociodemographic characteristics associated with CRC screening overall and by age group using separate multivariable logistic regression models.

Results

76% of eligible adults had received screening for CRC. Increasing age, Black racial group [OR 1.45; 95% CI (1.07, 1.97)], having some college experience, a college degree or higher [OR 1.69; 95% CI (1.24, 2.29)], health insurance coverage [OR 4.48; 95% CI (2.96, 6.76)], primary care provider access [OR 2.48; 95% CI (1.91, 3.22)] and presence of a comorbid illness [OR 1.39; 95% CI (1.12, 1.73)] were independent predictors of CRC screening. Current smokers were less likely to undergo CRC screening [OR 0.59; 95% CI (0.40, 0.87)]. Among adults aged 50–64 years, being of Hispanic origin [OR 0.60; 95% CI (0.39, 0.92)] was associated with a lower likelihood of CRC screening.

Conclusion

CRC screening rates among adults 45–49 years are low but are increasing steadily. Odds of CRC screening among Blacks is high which is encouraging while the odds among current smokers is low and concerning given their increased risk of developing CRC.
Literature
1.
2.
3.
Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, Davis EM, US Preventive Services Task Force (2021) Screening for colorectal cancer: US preventive services task force recommendation statement. JAMA 325(19):1965–1977 CrossRefPubMed
4.
Chang SH, Patel N, Du M, Liang PS (2022) Trends in early-onset vs late-onset colorectal cancer incidence by race/ethnicity in the United States Cancer statistics database. Clin Gastroenterol Hepatol 20(6):e1365–e1377 CrossRefPubMed
5.
Mauri G, Sartore-Bianchi A, Russo AG, Marsoni S, Bardelli A, Siena S (2019) Early-onset colorectal cancer in young individuals. Mol Oncol 13(2):109–131 CrossRefPubMed
6.
7.
Wolf AMD, Fontham ETH, Church TR, Flowers CR, Guerra CE, LaMonte SJ, Etzioni R, McKenna MT, Oeffinger KC, Shih Y-CT, Walter LC, Andrews KS, Brawley OW, Brooks D, Fedewa SA, Manassaram-Baptiste D, Siegel RL, Wender RC, Smith RA (2018) Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA: Cancer J Clin 68(4):250–281. https://​doi.​org/​10.​3322/​caac.​21457 CrossRefPubMed
8.
Joseph DA, King JB, Dowling NF, Thomas CC, Richardson LC (2020) Vital signs: colorectal cancer screening test use—United States, 2018. Morb Mortal Wkly Rep 69(10):253 CrossRef
9.
10.
11.
Rogers CR, Korous KM, Brooks E, De Vera MA, Tuuhetaufa F, Lucas T et al (2022) Early-onset colorectal cancer survival differences and potential geographic determinants among men and women in Utah. Am Soc Clin Oncol Educ Book 42:1–16 PubMedPubMedCentral
12.
13.
Yach D (2004) The Health Information National Trends Survey (HINTS): development, design, and dissemination. J Health Commun 9(5):481–482 CrossRef
14.
von Elm E, Altman DG, Egger M et al (2008) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 61(4):344–349 CrossRef
15.
Mojica CM, Lind B, Gu Y, Coronado GD, Davis MM (2021) Predictors of colorectal cancer screening modality among newly age-eligible medicaid enrollees. Am J Prev Med 60(1):72–79 CrossRefPubMed
16.
Giovannucci E (2001) An updated review of the epidemiological evidence that cigarette smoking increases risk of colorectal cancer. Cancer Epidemiol Biomark Prev 10(7):725–731
17.
Baidoun F, Elshiwy K, Elkeraie Y, Merjaneh Z, Khoudari G, Sarmini MT et al (2021) Colorectal cancer epidemiology: recent trends and impact on outcomes. Curr Drug Targets 22(9):998–1009 CrossRefPubMed
18.
Taber JM, Klein WM, Suls JM, Ferrer RA (2017) Lay awareness of the relationship between age and cancer risk. Ann Behav Med 51(2):214–225 CrossRefPubMed
19.
Rim SH, Joseph DA, Steele CB, Thompson TD, Seeff LC, Centers for Disease Control and Prevention (CDC) (2011) Colorectal cancer screening—United States, 2002, 2004, 2006, and 2008. MMWR Surveill Summ 60(Suppl):42–46
20.
Heflin MT, Oddone EZ, Pieper CF, Burchett BM, Cohen HJ (2002) The effect of comorbid illness on receipt of cancer screening by older people. J Am Geriatr Soc 50(10):1651–1658 CrossRefPubMed
21.
Wools A, Dapper EA, Leeuw JD (2016) Colorectal cancer screening participation: a systematic review. Eur J Public Health 26(1):158–168 CrossRefPubMed
22.
Subramanian S, Klosterman M, Amonkar MM, Hunt TL (2004) Adherence with colorectal cancer screening guidelines: a review. Prev Med 38(5):536–550 CrossRefPubMed
23.
Cole AM, Jackson JE, Doescher M (2012) Urban–rural disparities in colorectal cancer screening: cross-sectional analysis of 1998–2005 data from the centers for disease control’s behavioral risk factor surveillance study. Cancer Med 1(3):350–356 CrossRefPubMedPubMedCentral
24.
25.
Von Wagner C, Semmler C, Good A, Wardle J (2009) Health literacy and self-efficacy for participating in colorectal cancer screening: the role of information processing. Patient Educ Couns 75(3):352–357 CrossRef
26.
Wee CC, McCarthy EP, Phillips RS (2005) Factors associated with colon cancer screening: the role of patient factors and physician counseling. Prev Med 41(1):23–29 CrossRefPubMed
27.
Carmichael H, Cowan M, McIntyre R, Velopulos C (2020) Disparities in colorectal cancer mortality for rural populations in the United States: does screening matter? Am J Surg 219(6):988–992 CrossRefPubMed
28.
Shete S, Deng Y, Shannon J, Faseru B, Middleton D, Iachan R et al (2021) Differences in breast and colorectal cancer screening adherence among women residing in urban and rural communities in the United States. JAMA Netw Open 4(10):e2128000–e2128000 CrossRefPubMedPubMedCentral
29.
Hu J, Wu Y, Ji F, Fang X, Chen F (2020) Peer support as an ideal solution for racial/ethnic disparities in colorectal cancer screening: evidence from a systematic review and meta-analysis. Dis Colon Rectum 63(6):850–858 CrossRefPubMed
30.
Leone LA, Allicock M, Pignone MP, Walsh JF, Johnson L-S, Armstrong-Brown J, Carr CC, Langford A, Ni A, Resnicow K, Campbell MK (2016) Cluster randomized trial of a church-based peer counselor and tailored newsletter intervention to promote colorectal cancer screening and physical activity among older African Americans. Health Educ Behav 43(5):568–576. https://​doi.​org/​10.​1177/​1090198115611877​ CrossRefPubMed
31.
Lawrence D, Weigel L, Dale P, Smith B, Honaker MD (2017) Presenting stage in colon cancer is associated with insurance status. Am Surg 83(7):728–732 CrossRefPubMed
32.
Hoehn RS, Rieser CJ, Phelos H, Sabik LM, Nassour I, Paniccia A (2021) Association between Medicaid expansion and diagnosis and management of colon cancer. J Am Coll Surg 232(2):146–156 CrossRefPubMed
33.
Brewer KC, Peacock NR, Ferrans CE, Campbell RT, Polite B, Carnahan L et al (2020) Gender-and race-based differences in barriers and facilitators to early detection of colon cancer. J Women’s Health 29(9):1192–1202 CrossRef
34.
Lukin DJ, Jandorf LH, Dhulkifl RJ, Thélémaque LD, Christie JA, Itzkowitz SH, DuHamel KN (2012) Effect of comorbid conditions on adherence to colorectal cancer screening. J Cancer Educ 27(2):269–276 CrossRefPubMedPubMedCentral
35.
Guiriguet C, Pera G, Castells A, Toran P, Grau J, Rivero I et al (2017) Impact of comorbid conditions on participation in an organised colorectal cancer screening programme: a cross-sectional study. BMC Cancer 17(1):1–10 CrossRef
36.
Perea MD, Castano-Vinyals G, Altzibar JM, Ascunce N, Moreno V, Tardon A et al (2012) Cancer screening practices and associated lifestyles in population controls of the Spanish multi-case control study. Gac Sanit 26(4):301–310 PubMed
37.
Carrasco-Garrido P, Hernandez-Barrera V, Lopez de Andres A, Jimenez-Trujillo I, Gallardo Pino C, Jimenez-Garcıa R (2014) Awareness and uptake of colorectal, breast, cervical and prostate cancer screening tests in Spain. Eur J Public Health 24(2):264–270 CrossRefPubMed
38.
Liu BY, O’Malley J, Mori M, Fagnan LJ, Lieberman D, Morris CD et al (2014) The association of type and number of chronic diseases with breast, cervical, and colorectal cancer screening. J Am Board Family Med 27(5):669–681 CrossRef
39.
Castañeda SF, Gallo LC, Nodora J, Talavera GA, Penedo FJ, Evenson KR et al (2019) Colorectal cancer screening among hispanics/latinos in the HCHS/SOL sociocultural ancillary study. Prev Med Rep 15:100947 CrossRefPubMedPubMedCentral
40.
Ansa BE, Coughlin SS, Alema-Mensah E, Smith SA (2018) Evaluation of colorectal cancer incidence trends in the United States (2000–2014). J Clin Med 7(2):22 CrossRefPubMedPubMedCentral
41.
May FP, Glenn BA, Crespi CM, Ponce N, Spiegel BM, Bastani R (2017) Decreasing black-white disparities in colorectal cancer incidence and stage at presentation in the United States improving colorectal cancer disparities. Cancer Epidemiol Biomark Prev 26(5):762–768 CrossRef
42.
Lee DC, Liang H, Chen N, Shi L, Liu Y (2020) Cancer screening among racial/ethnic groups in health centers. Int J Equity Health 19(1):1–7 CrossRef
43.
Agrawal S, Bhupinderjit A, Bhutani MS, Boardman L, Nguyen C, Romero Y et al (2005) Colorectal cancer in African americans. Official J Am College Gastroenterol 100(3):515–523 CrossRef
44.
45.
46.
47.
48.
Robie L, Alexandru D, Bota DA (2011) The use of patient navigators to improve cancer care for hispanic patients. Clin Med Insights: Oncol 5:CMO-S6074
49.
Viramontes O, Bastani R, Yang L, Glenn BA, Herrmann AK, May FP (2020) Colorectal cancer screening among hispanics in the United States: disparities, modalities, predictors, and regional variation. Prev Med 138:106146 CrossRefPubMed
50.
Hama H, Tabuchi T, Ito Y, Fukushima W, Matsunaga I, Miyashiro I, Nakayama T (2016) Smoking behavior and participation in screening for lung, gastric, and colorectal cancers. Jpn J Public Health 63(3):126–134
51.
Sanford NN, Sher DJ, Butler S, Xu X, Ahn C, D’Amico AV et al (2019) Cancer screening patterns among current, former, and never smokers in the United States, 2010–2015. JAMA Netw Open 2(5):e193759–e193759 CrossRefPubMedPubMedCentral
Metadata
Title
Prevalence and predictors of colorectal cancer screening in the United States: evidence from the HINTS database 2018 to 2020
Authors
Joseph Atarere
Christopher Haas
Ted Akhiwu
Thilini Delungahawatta
Ashik Pokharel
Comfort Adewunmi
Eugene Annor
Vwaire Orhurhu
Jasmine Barrow
Publication date
22-09-2023
Publisher
Springer International Publishing
Published in
Cancer Causes & Control
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-023-01795-8

European Society for Medical Oncology Congress 2023

NSCLC Video

ESMO23: Non-small-cell lung cancer highlights

Watch the panel discussion

Dr. Luis Paz-Ares, Prof. Solange Peters and Dr. Marina Garassino provide their insights on the latest findings from the following pivotal phase III trials: ALINA, CheckMate-77T, LIBRETTO-431, and MARIPOSA-1 and -2.

Supported by: F. Hoffmann-La Roche Ltd.
Dr. Luis Paz-Ares
Prof. Solange Peters
Dr. Marina Garassino

ESMO23: Small-cell lung cancer highlights

SCLC Expert Interview

Cancer of Unknown Primary: Key results from ESMO 2023

Cancer of Unknown Primary Expert Interview

Tisotumab vedotin improves recurrent and metastatic cervical cancer survival

25-10-2023 Cervical Cancer News

EV-302 heralds practice change for advanced urothelial cancer

24-10-2023 Urothelial Cancer News

First-line selpercatinib supported for RET-mutant medullary thyroid cancer

23-10-2023 Thyroid Cancer News

» View more highlights on the ESMO 2023 hub page

Test your knowledge with Case-Based Clinical Insights

Oncology and Hematology Cases

45/♀ with increasing weakness, loss of appetite, diarrhoea and oedema – Case 29

Case-Based Insights: Oncology and Hematology Training Course

A 45-year-old female patient complains that she has been getting weaker and weaker for several months. She has no appetite and suffers from diarrhoea. Immunofixation shows monoclonal lambda light chains in the serum. What is your tentative diagnosis?

48/♀ with increasing spontaneous haematomas all over her body – Case 37

Case-Based Insights: Oncology and Hematology Training Course

A 48-year-old female patient feels listless and reports petechiae occurred for the first time. In the last 3 days, she had reportedly developed severe toothache and fever. The blood count shows severe pancytopenia. What are your first steps?

49/♀ with lymphoedema of the arm in condition of metastasised triple-negative breast carcinoma – Case 43

Case-Based Insights: Oncology and Hematology Training Course

The 49-year-old female patient presents with significant swelling of the right arm. She reports having been diagnosed with breast cancer 1½ years ago, followed by surgical removal of the tumour. She had then received chemotherapy and irradiation. How do you proceed?

53/♂ with movement-dependent pain in the left anterior pelvis and bloody urine – Case 39

Case-Based Insights: Oncology and Hematology Training Course

A 53-year-old man complains of increasing pain in the left anterior pelvis, which is described as movement-dependent with radiation into the left lower extremity. For several months, he had noticed bloody urine from time to time without pain during micturition. What are your suspicions?

Image Credits